ExCulture is grateful to have been invited to join the 30th Symposium of Glycosaminoglycans, to participate in thought-provoking conversations with global experts who are exploring the latest developments in chemistry, biochemistry, biology, pharmacology and the clinical applications of heparin and other glycosaminoglycans. The symposium was organised by the Istituto di Ricerche Chimiche e Biochimiche “G. Ronzoni”, Milan Italy, the University of Bonn and University of Münster, Germany.
ExCulture secures funding from the Dutch Industrial Biotech Seed Fund (managed by Capricorn Partners) and TTT Medtech
Leiden, 12th July 2024 - ExCulture B.V., a biotechnology startup focused on the development of an animal-free heparin substitute via fermentation,...